TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35051151

Group type: EXPERIMENTAL
Intervention: Ozone therapy (intraarticular O2-O3 mixture hip injections with ozonated autohemotherapy)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Ozone therapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control (protected weight bearing)
Number of subjects: 71
Study: 34700600

Group type: EXPERIMENTAL
Intervention: DWI-guided dose-painting radiotherapy (DP-RT)
Number of subjects: 186

Group type: COMPARATOR
Intervention: CT-based radiotherapy
Number of subjects: 186
Study: 32312010

Group type: EXPERIMENTAL
Intervention: HBO therapy (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: No HBO therapy (Group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal control (Group C)
Number of subjects: 30
Study: 34687214

Group type: EXPERIMENTAL
Intervention: Bimekizumab 320 mg at weeks 0/4, followed by bimekizumab 320 mg at week 16
Number of subjects: 49

Group type: COMPARATOR
Intervention: Bimekizumab 320 mg at weeks 0/4, followed by placebo at week 16
Number of subjects: 49
Study: 33685888

Group type: EXPERIMENTAL
Intervention: Standard regimen (2.4 mg/kg body weight i.v. artesunate at 0 and 12 h)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Simplified regimen (4 mg/kg i.v. artesunate at 0 h)
Number of subjects: 94
Study: 32853275

Group type: EXPERIMENTAL
Intervention: Energy-conservation PR
Number of subjects: 176

Group type: COMPARATOR
Intervention: Traditional PR
Number of subjects: 176
Study: 34583525

Group type: EXPERIMENTAL
Intervention: Autologous mesenchymal stem cell (MSC) treatment
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 34425767

Group type: EXPERIMENTAL
Intervention: Persistent loneliness
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Intermittent loneliness
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Persistent social isolation
Number of subjects: 224

Group type: COMPARATOR
Intervention: Never lonely (reference group)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Not socially isolated (reference category)
Number of subjects: 224
Study: 36209084

Group type: EXPERIMENTAL
Intervention: Aerobic Training + Vitamin D supplementation (AT+Vit D)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (Vit D)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control + Placebo (C)
Number of subjects: 40
Study: 33413233

Group type: EXPERIMENTAL
Intervention: Group-based intervention consisting of 12 weekly sessions delivered in primary care settings and community assets.
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Group-based intervention.
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group (CG).
Number of subjects: 390
Study: 32604296

Group type: EXPERIMENTAL
Intervention: New incision design (n = 24)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional surgery (n = 24)
Number of subjects: 48
Study: 33902493

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (8 sessions, 1 hour each) for parents or guardians
Number of subjects: 50
Study: 33811980

Group type: EXPERIMENTAL
Intervention: Instrumental variable analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33167321

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-TRE
Number of subjects: 20
Study: 35908457

Group type: EXPERIMENTAL
Intervention: oral conjugated equine estrogens (o‐CEE, n = 104)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: transdermal 17β‐estradiol (t‐E2, n = 119)
Number of subjects: 374

Group type: COMPARATOR
Intervention: placebo (n = 115)
Number of subjects: 374
Study: 33758944

Group type: EXPERIMENTAL
Intervention: Strawberry consumption (2 × 25 g freeze-dried strawberry powder twice daily for 4 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control beverage (energy-, volume-matched control powder for 4 weeks)
Number of subjects: 34
Study: 35245224

Group type: EXPERIMENTAL
Intervention: Oxygen Reserve Index (ORI) group
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: ORI group
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 124
Study: 32343288

Group type: EXPERIMENTAL
Intervention: Patients who continued in the trial
Number of subjects: 18

Group type: COMPARATOR
Intervention: Patients who dropped out of the trial
Number of subjects: 18
Study: 35476320

Group type: EXPERIMENTAL
Intervention: Telemedicine-assisted self-monitoring blood glucose (Group A)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard self-monitoring blood glucose (Group B)
Number of subjects: 123
Study: 33481009

Group type: EXPERIMENTAL
Intervention: Brain-derived gene expression
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: Whole blood analyses
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: FURIN locus
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: SLC12A5 locus
Number of subjects: 1194
Study: 36433709

Group type: EXPERIMENTAL
Intervention: Janagliflozin 25 mg
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Janagliflozin 50 mg
Number of subjects: 421

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Janagliflozin 25 mg and 50 mg
Number of subjects: 421
Study: 33434289

Group type: EXPERIMENTAL
Intervention: Post-selection inference methods tailored toward changepoint detection using binary segmentation, wild and circular variants, and fused lasso.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Markov chain Monte Carlo algorithms (importance sampling and hit-and-run sampling) used in tests.
Number of subjects: 0
Study: 33443971

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4401

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4401
Study: 33378510

Group type: EXPERIMENTAL
Intervention: APC flash‐free brackets
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional ceramic brackets
Number of subjects: 30
Study: 32171183

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) applied with a lymphatic correction technique in three-four day intervals for four weeks.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Compression garment (CG) worn daily for 23 hours.
Number of subjects: 35
Study: 35594919

Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 40
Study: 34157494

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no reflexology)
Number of subjects: 62
Study: 32195805

Group type: EXPERIMENTAL
Intervention: rhGH treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 60
Study: 36232995

Group type: EXPERIMENTAL
Intervention: Citrate Dialysate (1 mmol/L)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Acetate Dialysate (4 mmol/L)
Number of subjects: 21
Study: 36482606

Group type: EXPERIMENTAL
Intervention: HIPEC with cisplatin and intraperitoneal perfusion with rmhTNF‐NC
Number of subjects: 20
Study: 32447722

Group type: EXPERIMENTAL
Intervention: Alemtuzumab treatment
Number of subjects: 35
Study: 33113783

Group type: EXPERIMENTAL
Intervention: Carvacrol (100%, 75%, and 50%)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control drug (10% ethanol)
Number of subjects: 42
Study: 36078234

Group type: EXPERIMENTAL
Intervention: Nine-Square Step Exercises (NSSE) for at least 45 days over 8 weeks
Number of subjects: 46
Study: 33556067

Group type: EXPERIMENTAL
Intervention: Wearing clinical compression socks (20-30 mmHg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Wearing non-clinical compression socks (< 20 mmHg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Wearing normal socks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Barefoot
Number of subjects: 26
Study: 32847838

Group type: EXPERIMENTAL
Intervention: Cabozantinib (60 mg daily)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 495
Study: 35966245

Group type: EXPERIMENTAL
Intervention: 23G minimally invasive vitrectomy combined with glaucoma drainage valve implantation
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 23G minimally invasive vitrectomy combined with phacoemulsification cataract extraction
Number of subjects: 83

Group type: COMPARATOR
Intervention: 23G minimally invasive vitrectomy combined with glaucoma drainage valve implantation and phacoemulsification cataract extraction
Number of subjects: 83
Study: 33744668

Group type: EXPERIMENTAL
Intervention: Sharing IDPE alone
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Sharing needles with or without IDPE
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Baseline SSTI
Number of subjects: 252
Study: 35084634

Group type: EXPERIMENTAL
Intervention: Intralesional platelet-rich plasma (PRP) injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: 1064 nm long-pulsed Nd:YAG laser
Number of subjects: 30
Study: 35950601

Group type: EXPERIMENTAL
Intervention: Generic (test) edoxaban 60-mg tablet in fasting condition
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Generic (test) edoxaban 60-mg tablet in fed condition
Number of subjects: 64

Group type: COMPARATOR
Intervention: Branded (reference) edoxaban 60-mg tablet in fasting condition
Number of subjects: 64

Group type: COMPARATOR
Intervention: Branded (reference) edoxaban 60-mg tablet in fed condition
Number of subjects: 64
Study: 33563752

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination treatment with FGFR and MEK inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FGFR-specific inhibitors (BGJ398, erdafitinib, TAS-120)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33372072

Group type: EXPERIMENTAL
Intervention: Carnosine supplementation for 12 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 32969040

Group type: EXPERIMENTAL
Intervention: Closed loop automated oxygen control system
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 24
Study: 36079874

Group type: EXPERIMENTAL
Intervention: Early standardized lunch at 12:00 (12S)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Late standardized lunch at 14:00 (14S)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Apple preload to early standardized lunch (12A+S)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Apple preload to late standardized lunch (14A+S)
Number of subjects: 26
Study: 32668456

Group type: EXPERIMENTAL
Intervention: 800 mg albendazole
Number of subjects: 466

Group type: COMPARATOR
Intervention: 200 mg albendazole
Number of subjects: 466

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 466
Study: 32641091

Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate treatment for no more than 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir treatment for no more than 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate treatment
Number of subjects: 0
Study: 36155062

Group type: EXPERIMENTAL
Intervention: 0.5 g% MSG in drinking water
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1.5 g% MSG in drinking water
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3.0 g% MSG in drinking water
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3.0 g% MSG in drinking water (withdrawn after 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard diet (control group)
Number of subjects: 40
Study: 33781103

Group type: EXPERIMENTAL
Intervention: MDMA (75mg or 125mg)
Number of subjects: 194
Study: 32808888

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 27
Study: 36468509

Group type: EXPERIMENTAL
Intervention: Self-adhesive mesh (S group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional polypropylene mesh (P group)
Number of subjects: 100
Study: 34607077

Group type: EXPERIMENTAL
Intervention: Single session of physiotherapy and self-management (ARTISAN intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care physiotherapy
Number of subjects: 0
Study: 33124791

Group type: EXPERIMENTAL
Intervention: Statins (10 mg of rosuvastatin)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Placebo + Exercise Training (PLET)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Statins + Exercise Training (STAET)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Statins (STA)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 83
Study: 35697491

Group type: EXPERIMENTAL
Intervention: Neuromuscular-based training workout, 5 times per week for 10 weeks, 20 to 30 minutes per session
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Neuromuscular-based training workout
Number of subjects: 22
Study: 32972483

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for psychosis (CBTp) using a novel tabletised manual
Number of subjects: 24
Study: 33080100

Group type: EXPERIMENTAL
Intervention: cetuximab + M (one-arm design)
Number of subjects: 135

Group type: COMPARATOR
Intervention: cetuximab (two-arm design)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: cetuximab + M (two-arm design)
Number of subjects: 135

Group type: COMPARATOR
Intervention: cetuximab (four-arm design)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: cetuximab + M (four-arm design)
Number of subjects: 135
Study: 35209775

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS)
Number of subjects: 25198

Group type: EXPERIMENTAL
Intervention: CDS plus Shared Decision Making (CDS+SDM)
Number of subjects: 25198

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 25198
Study: 32845399

Group type: EXPERIMENTAL
Intervention: Permanent suture (Gore‐Tex)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Absorbable suture (PDS)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups (Gore‐Tex and PDS)
Number of subjects: 200
Study: 32305186

Group type: COMPARATOR
Intervention: Multiple arterial graft (MAG) group (2 or more arterial grafts with additional saphenous veins)
Number of subjects: 2484

Group type: COMPARATOR
Intervention: Total arterial graft (TAG) group (3 or more arterial grafts only)
Number of subjects: 2484
Study: 33257297

Group type: EXPERIMENTAL
Intervention: Video plus mental training group
Number of subjects: 24
Study: 35585570

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of conbercept (IVC) 3 days before PPV
Number of subjects: 34

Group type: COMPARATOR
Intervention: Intravitreal injection of conbercept (IVC) after PPV
Number of subjects: 34

Group type: COMPARATOR
Intervention: Aqueous humor from age-matched cataract patients (control group)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Non-bleeding (INB) group
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intraoperative bleeding (IOB) group
Number of subjects: 34
Study: 33128790

Group type: EXPERIMENTAL
Intervention: COPE‐TeL programme (12-week intervention including comprehensive oral and physical exercises and textured lunch gatherings)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Physical exercise regimen only (control group)
Number of subjects: 86
Study: 35306161

Group type: COMPARATOR
Intervention: Spinal Anesthesia (Control)
Number of subjects: 152
Study: 34267185

Group type: EXPERIMENTAL
Intervention: Low dose vaccine
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: High dose vaccine
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1128
Study: 32521054

Group type: EXPERIMENTAL
Intervention: Shikani optical stylet (SOS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: fiberoptic bronchoscope (FOB)
Number of subjects: 50
Study: 33024237

Group type: EXPERIMENTAL
Intervention: Eplerenone (25 mg/day)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 35100493

Group type: EXPERIMENTAL
Intervention: LC hair essence serum injection (1 ml diluted with 0.5 ml of 0.9% normal saline, once weekly for 8 weeks)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Botulinum toxin-A injection (50 units)
Number of subjects: 62
Study: 33279467

Group type: EXPERIMENTAL
Intervention: ACT with CF (telehealth)
Number of subjects: 28

Group type: COMPARATOR
Intervention: ACT with CF (in-person)
Number of subjects: 28
Study: 33514393

Group type: EXPERIMENTAL
Intervention: Power-assisted ankle robot (PAAR)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Swing-controlled ankle robot (SCAR)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional training (CT)
Number of subjects: 47
Study: 32648771

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA)
Number of subjects: 1701
Study: 35076685

Group type: EXPERIMENTAL
Intervention: Device closure of patent foramen ovale
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34281754

Group type: EXPERIMENTAL
Intervention: Workshops‐Only
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Workshops + SMS/texting
Number of subjects: 184

Group type: COMPARATOR
Intervention: No‐Intervention‐Control
Number of subjects: 184
Study: 33238829

Group type: EXPERIMENTAL
Intervention: Intraoperative stent
Number of subjects: 283

Group type: COMPARATOR
Intervention: Nonintraoperative stent
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Intraoperative stent with ileal conduit
Number of subjects: 283
Study: 36042439

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (PN) commenced on day 1 or day 2 of admission
Number of subjects: 60

Group type: COMPARATOR
Intervention: Late parenteral nutrition (PN) commenced on day 6 of admission
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Early PN
Number of subjects: 60

Group type: COMPARATOR
Intervention: Late PN
Number of subjects: 60
Study: 33960081

Group type: EXPERIMENTAL
Intervention: Saffron 100 mg/day for 8 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 70
Study: 32067381

Group type: EXPERIMENTAL
Intervention: 1.5% dexamethasone nanoparticle (DexNP) eye drops postoperatively
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mitomycin C (MMC) and Maxidex® eye drops postoperatively
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 33481863

Group type: EXPERIMENTAL
Intervention: Postpartum mothers with family monthly income <150 USD
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Postpartum mothers whose husbands had migrated for employment
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Postpartum mothers with nearest health facility located at more than 60 minutes walking distance
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Postpartum mothers who delivered their last child by cesarean section
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Postpartum mothers who received less than four recommended antenatal care visits
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Postpartum mothers who had planned pregnancy
Number of subjects: 415
Study: 32066784

Group type: EXPERIMENTAL
Intervention: FLG loss-of-function (LOF) variants
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Two or more FLG LOF variants
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: All detected FLG LOF variants
Number of subjects: 386

Group type: COMPARATOR
Intervention: Rare variants in the EDC region
Number of subjects: 386
Study: 36260577

Group type: EXPERIMENTAL
Intervention: Exoskeleton-assisted walking (EAW)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional exercise program
Number of subjects: 40
Study: 34280529

Group type: EXPERIMENTAL
Intervention: Corticospinal tract (CST) microstructure analysis using fractional anisotropy and mean diffusivity
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Circle drawing task (dexterity measure)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Linear regression analyses
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Bayesian regression analysis
Number of subjects: 199
Study: 32948138

Group type: EXPERIMENTAL
Intervention: Lower Criteria Group (fasting plasma glucose < 5.1 mmol/L, AND 1 hour < 10.0 mmol/L, AND 2 hour < 8.5 mmol/L)
Number of subjects: 4158

Group type: COMPARATOR
Intervention: Higher Criteria Group (fasting plasma glucose < 5.5 mmol/L, AND 2 hour < 9.0 mmol/L)
Number of subjects: 4158

Group type: EXPERIMENTAL
Intervention: Lower Criteria Group
Number of subjects: 4158

Group type: COMPARATOR
Intervention: Higher Criteria Group
Number of subjects: 4158
Study: 35644623

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation (LKM) training for 8 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 33677737

Group type: EXPERIMENTAL
Intervention: CDP‐VR
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vertiguard‐VR
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 40
Study: 32444327

Group type: EXPERIMENTAL
Intervention: Epalrestat
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 35000838

Group type: EXPERIMENTAL
Intervention: EMLA + Sucrose + RB + Music
Number of subjects: 103

Group type: COMPARATOR
Intervention: EMLA + Sucrose + RB
Number of subjects: 103
Study: 34130017

Group type: EXPERIMENTAL
Intervention: Rapid digesting carbohydrate (RDC)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Slow digesting carbohydrate (SDC)
Number of subjects: 19
Study: 35045272

Group type: EXPERIMENTAL
Intervention: Male-predominant plasma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma from multiparous donors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consensus panel definitions (TRALI type I and TRALI type II)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical expertise in critical care or pulmonary medicine
Number of subjects: 0